ArticleThe oncologist2024

Treatment Outcomes in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid and/or Rhabdoid Dedifferentiation After Progression on Immune Checkpoint Therapy.

Andrew W Hahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.